International Development Grant
COVID-19 vaccine research and development
Project Number: CA-3-P009527001
Status: Closed
Country/Region: Unknown
Regional Focus:
Maximum Contribution: $40,000,000.00
Start Date: August 04, 2020
End Date: December 31, 2021
Duration: 1.4 years
Project Description
This project aims to support the Coalition for Epidemic Preparedness Innovations (CEPI) to help the development manufacture and ultimate distribution of up to 1.2 billion COVID-19 vaccine(s) through a fair allocation system within 12 to18 months. Project activities include: (1) supporting research and development of up to 5 vaccine candidates; and (2) supporting manufacturing and distribution of up to 1.2 billion vaccine doses by 2021.
Expected Results
The expected outcomes of this project include: (1) strengthened global preparedness for known epidemic and pandemic threats; (2) strengthened global response to emerging pandemic threats; and (3) improved collaboration between public and private pandemic preparedness and response stakeholders.
Progress & Results Achieved
Results achieved as of May 2022 include: (1) developed 8 COVID-19 vaccine candidates with CEPI support. 7 of them progressed into Phase II or III clinical trials; (2) the World Health Organization authorized 3 COVID-19 vaccine candidates (Astra Zeneca Moderna and Novavax) for emergency use; (3) 5 candidates (AZ/Uni Oxford CureVac Clover Moderna and Novavax ) published primary endpoint analysis of pivotal trial (AZ/Uni Oxford Moderna Novavax CureVac and Clover); and (4) delivered over 900 million COVID-19 vaccine doses in 2021 (reaching 95% of target).
Key Information
Executing Agency:
Coalition for Epidemic Preparedness
Reporting Organization:
Global Affairs Canada
Program:
YFMInternaAssistPartnershp&Programing Br
Last Modified:
September 19, 2025
Development Classifications
DAC Sector:
Aid Type: Core support to NGOs other private bodies PPPs and research institutes
Collaboration: Bilateral core contributions to NGOs and other private bodies / PPPs
Finance Type: Aid grant excluding debt reorganisation
Selection Mechanism:
Department-Initiated